Screener
Olema Pharmaceuticals, Inc. OLMA Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Olema Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The source filing: Olema Pharmaceuticals, Inc.’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 7:10 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-218156
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Research and development | $$49,232 | 30,624 |
| General and administrative | 8,754 | 4,249 |
| Total operating expenses | 57,986 | 34,873 |
| Loss from operations | (57,986) | (34,873) |
| Other income: | ||
| Interest income | 4,776 | 4,524 |
| Other income (loss) | 121 | (40) |
| Total other income | 4,897 | 4,484 |
Item 1. Financial Statements.
FAQ
- What is Olema Pharmaceuticals, Inc.'s operating income?
- Olema Pharmaceuticals, Inc. (OLMA) reported operating income of -$57.99M in Q1 2026.
- How has Olema Pharmaceuticals, Inc.'s operating income changed year-over-year?
- Olema Pharmaceuticals, Inc.'s operating income decreased by 66.3% year-over-year, from -$34.87M to -$57.99M.
- What is the long-term trend for Olema Pharmaceuticals, Inc.'s operating income?
- Over 4 years (2021 to 2025), Olema Pharmaceuticals, Inc.'s operating income has grown at a 25.7% compound annual growth rate (CAGR), from -$71.49M to -$178.7M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.
Ask your AI about Olema Pharmaceuticals, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude